Connection
Benjamin Click to Cost-Benefit Analysis
This is a "connection" page, showing publications Benjamin Click has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.286 |
|
|
|
-
Beard JA, Click BH. The burden of cost in inflammatory bowel disease: a medical economic perspective. Curr Opin Gastroenterol. 2020 07; 36(4):310-316.
Score: 0.145
-
Franco DL, Click B. Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze? Inflamm Bowel Dis. 2020 01 01; 26(1):112-113.
Score: 0.140